Skip to content

Type 2 Continuous Glucose Monitoring Academy

Randomized Control Trial Evaluating the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06516640
Enrollment
60
Registered
2024-07-24
Start date
2025-06-23
Completion date
2026-12-30
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Continuous Glucose Monitoring, Glycemic Control, Diabetes Education, Type 2 Diabetes

Brief summary

The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): * The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics. Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.

Interventions

BEHAVIORALContinuous Glucose Monitoring Academy

Educational materials as well as online sessions with diabetes educators.

BEHAVIORALStandard Education

Standard of care receives general education about diabetes.

Sponsors

Children's Hospital Los Angeles
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Current age of 8-21 years; 2. T2D diagnosis; 3. Able to speak, read, and write English or Spanish

Exclusion criteria

a. Known history of medical adhesive allergies;

Design outcomes

Primary

MeasureTime frameDescription
Mean change in Time in Range (TIR) from baseline to 6 monthsBaseline to 6 monthsChange in % glucose TIR (70-180 mg/dL)

Secondary

MeasureTime frameDescription
Mean change in Hemoglobin A1c (HbA1c) from baseline to 6 monthsBaseline to 6 monthsChange in Hemoglobin A1c
Mean change in CGM metrics measured by CGM readingsWeek 4 & 6 months% Glucose Time Below Range (\<70mg/dL), % Glucose Time Above Range (\>180mg/dL), % Glucose Variability (coefficient of variation, CV)
Change in perceived diabetes distress at baseline, week 4 & 6 monthsBaseline, Week 4 & 6 monthsThe Type 2 Diabetes Distress Assessment System (T2-DDAS) measures how much overall emotional distress is due to diabetes. Respondents are given statements about diabetes-related issues and indicate on a 5-point Likert scale (0 = not a problem, 1 = minor problem, 2 = moderate problem, 3 = somewhat serious problem, 4 = serious problem) the degree to which the statements are a problem. Increasing scores denote increased burden perceived.
Change in perceived diabetes family responsibility at baseline, week 4 & 6 monthsBaseline, week 4 & 6 monthsThe Diabetes Family Responsibility Questionnaire (DFRQ) is a 14-item validated survey assessing parental and child involvement in various diabetes management tasks. Youth and caregivers report on a 3-point scale (1=child, 2=equal, 3=parent) who is responsible for a given diabetes task. Higher scores indicate more parental involvement in diabetes management.
Average number of diabetes educator hours used per study participant at week 4 & 6 months.Week 4 and 6 monthsNumber of hours spent in diabetes education
Mean change in perceived benefits of Continuous Glucose (CGM) Monitor useWeek 4 & 6 monthsName of questionnaire: Adolescent Benefits and Burdens of CGM Survey - BenCGM \& BurCGM. Participants answer each question on a scale of Strong Disagree, Disagree, Neutral, Agree, Strongly Agree.
Mean change in perceived burden of Continuous Glucose Monitor (CGM) useWeek 4 & 6 monthsName of questionnaire: Adolescent Benefits and Burdens of CGM Survey - BenCGM \& BurCGM. Participants answer each question on a scale of Strong Disagree, Disagree, Neutral, Agree, Strongly Agree.

Countries

United States

Contacts

CONTACTNatalia Garban
ngarban@chla.usc.edu3233611359
CONTACTRebecca Barber
rbarber@chla.usc.edu3233611359
PRINCIPAL_INVESTIGATORRebecca Barber, PhD, RN

Children's Hospital Los Angeles

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026